Lv1
50 积分 2026-02-27 加入
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study
5小时前
待确认
Fruquintinib plus sintilimab in advanced cervical cancer: an open-label, multicentre, phase 2 study
7天前
已完结
Efficacy and safety of cadonilimab combined with chemotherapy as first-line treatment for primary advanced or recurrent endometrial cancer: An interim analysis of a prospective, single-arm, open-label phase II trial
10天前
已完结
Autologous CD19 CAR T-cell therapy for pediatric and adult systemic lupus erythematosus: a phase 1/2 trial
22天前
已完结
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA
1个月前
已完结
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial
1个月前
已完结
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers
1个月前
已完结
Selinexor Delays Wild-type TP53 Endometrial Cancer Progression
2个月前
已完结
皖公网安备34019202002308
